All together, these results suggest that inhibition of NRF2 is related with the enhancement of the sensitivity of these cells to chemotherapeutic agents and the expression of cancer cell stemness biomarker as ALDH1A1 and ALDH3A1. The gene discussed is ALDH1A1; the disease is cancer.